The ASTar Instrument and ASTar BC G- Kit offer the broadest combination of antimicrobials and dilution ranges in a single analysis for Gram-negative bacteria. The test enables the analysis of both fastidious and non-fastidious bacteria, for rapid fully automatic and comprehensive results that support optimal treatment decisions.

“We are delighted to announce that we now have started to include patient samples in the US clinical study for ASTar. The clinical study contains three parts where the prospective part is the last. We have installed ASTar at three US hospitals and they will collect up to 150 patient samples each. Considering the size of the hospitals, we believe that the prospective part should be completed in the beginning of next year.”, says Jonas Jarvius, CEO of Q-linea.

ASTar Instrument and ASTar BC G- Kit is CE-marked but not FDA 510(k)-cleared and not available for sale in the US.